The International journal of neuroscience , 37 1-2, 85-8
Gut and Gastrointestinal Research Gastrointestinal research on GHK-Cu is an emerging area that has received less systematic attention than dermal applications, but the mechanistic case is well grounded
Until well-designed clinical trials are conducted, BPC-157 should be considered investigational, and its use approached with caution
Peptide therapies should only be used under the supervision of a licensed healthcare provider
Researchers also explore GLP-3 - GLP-3 is a GLP-1 receptor agonist for metabolic and weight-loss research.
Gene Expression Modulation Transcriptomic analyses in cellular models have shown that GHK-Cu influences expression of a remarkably wide set of genes, with reported effects on pathways involved in: Extracellular matrix remodeling DNA repair Antioxidant response Inflammatory signaling Stem cell signaling markers This broad transcriptional footprint has been one of the most studied aspects of GHK-Cu in recent years